The Cardiology Journals of Omics International Play a Significant Role in Improving the Quality of Life in the Long-run
SINGAPORE and LONDON (PRWEB) November 05, 2018 -- Cardiology is a branch of internal medicine that deals with the diagnosis and treatment of various heart disorders, such as coronary artery disease, congenital heart defects, valvular heart disease, and heart failure. Subspecialties include cardiac electrophysiology, echocardiography, nuclear cardiology, and interventional cardiology. Since the 1980's, cardiology has mushroomed into a specialty, and a lot has been achieved in all the subspecialty areas. According to the WHO, cardiovascular diseases are the dominant cause of death globally (31% of all global deaths). It further estimates that by 2030, nearly 23.6 million people will die due to cardiovascular diseases, especially stroke and heart disease. The high prevalence of various heart diseases would remain a challenge for the next 30 years.
The global interventional cardiology market had been estimated at USD 14.69 billion in 2017, and is purported to reach USD 24.96 billion by the year 2027 (CAGR of 8.37%). The growth in the global cardiology market is driven by the technological advancements in interventional cardiology, the increase in the geriatric population, the rise in the incidence of cardiovascular diseases, change in lifestyle, and improved healthcare infrastructure in the emerging markets.
To counter such high disease burdens, access to the latest and most authoritative cardiology research is non-negotiable. The open access format of publishing is correctly positioned to fill this gap and ensure seamless transfer of scientific information across different peoples speaking different languages.
Omics International is one of the most noteworthy open access publishers. Its resume is decorated with more than a thousand scientific journals, showcasing ~50,000 research articles every year. Through the years, Omics has evolved into a family of journals dealing with subjects, such as medicine, clinical, pharmaceuticals, and engineering.
The cardiology journals of Omics deal with crucial topics, such as the cause, treatment, and management of heart conditions, and various new developments in cardiology devices. Some of these journals like Journal of Clinical & Experimental Cardiology, Anatomy & Physiology: Current Research, Interventional Cardiology, Internal Medicine: Open Access, Cardiovascular Pharmacology: Open Access, Journal of Cardiovascular Diseases & Diagnosis, and Journal of Vascular Medicine & Surgery hold a premier position in cardiology literature.
Dr. Srinubabu Gedela, the CEO of Omics International is cognizant of the current challenges in medicine and healthcare. He notes that reams of dubious information pertaining to medicine are openly accessible over the internet, which makes it impossible to distinguish authentic information from the fraudulent one. Dr. Srinubabu Gedela says- "Fake news and a few fake blogs are affecting the reputation of open access journals.”
The cardiology journals published by Omics serve as a comprehensive repository of original and trusted information in cardiology. In keeping with the basic tenets of the open access movement, these journals are dedicated to the free and unrestricted dissemination of scholarly information. At their core, they retain the belief that science must serve the society, and that knowledge must transform it.
Abhishek Babu, PULSUS GROUP, http://www.pulsus.com, +91 4047482201, [email protected]
Share this article